drugset / Trial / NCT03311269
A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency
RandomizedParallel-groupDouble-blindTreatment
Summary
VICARES is a prospective randomized, controlled, multi-center, double blind study treating venous insufficiency associated with incompetent saphenous veins with 1% and 3% Sodium Tetradecyl Sulfate (STS) solution utilizing the ClariVein system.
Timeline
- Start
- 2017-09-22
- Primary completion
- 2018-05-15
- Completion
- 2020-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sodium Tetradecyl Sulfate | Unknown | 1 % | — |
| Comparator | Sodium Tetradecyl Sulfate | Unknown | 3 % | — |